SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-037534
Filing Date
2012-06-21
Accepted
2012-06-21 16:12:08
Documents
1
Period of Report
2012-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd349418.html 4  
1 FORM 4 rrd349418.xml 4 2906
  Complete submission text file 0001181431-12-037534.txt   4341
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 208 S. AKARD ST. --- DALLAS TX 75202
Business Address
AMELIO GILBERT F (Reporting) CIK: 0001183247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 12919890